Skip to main content
. 2021 May 9;74(1):351–363. doi: 10.1002/hep.31677

TABLE 4.

Characteristics of Prioritized Patients

Transplanted Both UNOS‐MELD Transplanted reMELD‐Na Transplanted Not Transplanted P
n 1,105 143 143 5,553
Age at listing (mean [SD]) 53.42 (10.48) 48.73 (13.62) 55.29 (9.53) 54.09 (10.77) <0.001
Gender female (%) 362 (32.8) 66 (46.2) 44 (30.8) 1,750 (31.5) 0.003
Length (mean [SD]) 172.87 (10.88) 171.73 (8.85) 173.59 (10.16) 173.03 (9.56) 0.368
Weight (mean [SD]) 81.42 (18.43) 77.33 (18.19) 79.30 (18.30) 79.03 (17.41) <0.001
Disease (%) <0.001
Cirrhosis, alcohol associated 390 (35.3) 48 (33.6) 65 (45.5) 1,458 (26.3)
Cirrhosis, HCV 74 (6.7) 6 (4.2) 10 (7.0) 385 (6.9)
Cirrhosis, other causes 285 (25.8) 27 (18.9) 33 (23.1) 833 (15.0)
Cholestatic disease 113 (10.2) 15 (10.5) 7 (4.90) 811 (14.6)
HCC and cirrhosis 37 (3.3) 3 (2.1) 9 (6.3) 1,325 (23.9)
Other 207 (18.7) 44 (30.7) 19 (13.2) 739 (13.3)
Status after 90 days <0.001
Censored because of HU or NSE 52 (4.7) 9 (6.3) 8 (5.6) 1,578 (28.5)
Deceased 338 (30.7) 28 (19.6) 36 (25.2) 276 (5.0)
After removal but within 90 days 121 (11.0) 30 (21.0) 27 (18.9) 703 (12.7)
While waiting on WL 56 (5.1) 19 (13.3) 28 (19.6) 2,370 (42.8)
Transplanted 536 (48.6) 57 (39.9) 44 (30.8) 611 (11.0)
Days on WL (mean [SD]) 24.94 (78.46) 51.32 (114.64) 72.64 (132.97) 175.21 (304.96) <0.001
Serum measurement at listing (mean [SD])
Creatinine (mg/dL) 2.95 (8.51) 2.67 (9.43) 1.26 (0.48) 1.09 (1.18) <0.001
Bilirubin (mg/dL) 19.29 (14.10) 10.69 (9.08) 8.01 (5.96) 2.89 (3.51) <0.001
INR 2.43 (1.20) 2.37 (1.40) 1.74 (0.32) 1.30 (0.28) <0.001
Sodium (mmol/L) 134.26 (6.08) 138.21 (4.67) 127.34 (5.34) 137.76 (4.20) <0.001
(re)MELD score 30.95 (5.48) 25.57 (2.95) 21.10 (2.26) 12.91 (4.60) <0.001
Dialysis‐dependent (%) 165 (15.3) 21 (15.1) 0 (0.0) 87 (1.6) <0.001